Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05724784 · ClinicalTrials.gov registry record · NA

Development and Feasibility Testing of a Suicide Prevention Intervention for Sexual and Gender Minority Youth

A NA study of Suicidal Ideation and Psychological Distress, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT05724784 is a NA study of Suicidal Ideation and Psychological Distress that has completed, run by University of Pittsburgh. The registered enrollment target is 11 participants, below the 268-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05724784, a NA study of Suicidal Ideation and Psychological Distress, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop and test a brief, digital, suicide prevention intervention for sexual and gender minority (SGM) youth who have experienced cyberbullying. Leading up to this phase, the study team completed two prior study aims, focused on identifying perspectives of SGM youth's regarding their experiences with cyberbullying and priorities for an intervention, and a phase in which SGM youth codesigned the study's intervention with the study team. This resulted in the development of study's intervention, Flourish, which leverages a text messaging-based chatbot to reduce suicide risk following cyberbullying among SGM youth through improving distress tolerance, motivation for help-seeking, and social problem-solving. Current Study Aim: Conduct an open trial to assess the feasibility and acceptability of Flourish among cyberbullied SGM youth, ages 12-17 (N=10). Hypotheses: Feasibility will be evidenced by recruitment/retention rates \> 80% and use of Flourish among \> 70% of SGM youth. At follow-up, adolescents will report improved problem-solving capacity, distress tolerance, and motivation for help-seeking and reduced psychological distress and suicidal ideation compared to baseline.

Interventions

  • BEHAVIORAL Flourish

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2023-05-24
Est. Completion 2024-09-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05724784

The ClinicalTrials.gov registry entry for NCT05724784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (96% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Flourish is the first listed.

NCT05724784 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05724784 about?

NCT05724784 is a clinical study titled "Development and Feasibility Testing of a Suicide Prevention Intervention for Sexual and Gender Minority Youth". This study aims to develop and test a brief, digital, suicide prevention intervention for sexual and gender minority (SGM) youth who have experienced cyberbullying. Leading up to this phase, the study team completed two prior study aims, focused on identifying perspectives of SGM youth's regarding t...

What is the current status of trial NCT05724784?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2023-05-24. Estimated completion is 2024-09-30.

What conditions does trial NCT05724784 study?

This clinical trial studies the following conditions: Suicidal Ideation, Psychological Distress.

What interventions are being tested in trial NCT05724784?

The interventions under investigation include: Flourish (BEHAVIORAL).

Who is sponsoring clinical trial NCT05724784?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05724784 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.